Actavia Life Sciences (Actavia Life Sciences) YoY EBITDA Growth : 100.00% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Actavia Life Sciences YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Actavia Life Sciences's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 100.00%.

Actavia Life Sciences's EBITDA per Share for the three months ended in Mar. 2024 was $0.00.

Actavia Life Sciences YoY EBITDA Growth Historical Data

The historical data trend for Actavia Life Sciences's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actavia Life Sciences YoY EBITDA Growth Chart

Actavia Life Sciences Annual Data

Trend

Jun14

Jun15

Jun16

Mar17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

YoY EBITDA Growth

Get a 7-Day Free Trial

77.97

-492.31

93.51

140.00

-450.00

Actavia Life Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-450.00	-	-	100.00	100.00

Actavia Life Sciences YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Actavia Life Sciences's YoY EBITDA Growth for the fiscal year that ended in Sep. 2023 is calculated as:

	YoY EBITDA Growth (A: Sep. 2023 )
=	(EBITDA per Share (A: Sep. 2023 )	-	EBITDA per Share (A: Sep. 2022 ))	/	\| EBITDA per Share (A: Sep. 2022 ) \|
=	(-0.007	-	0.002)	/	\| 0.002 \|
=	-450.00 %

Actavia Life Sciences's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0	-	-0.007)	/	\| -0.007 \|
=	100.00 %

Actavia Life Sciences YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Actavia Life Sciences's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Actavia Life Sciences (Actavia Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actavia Life Sciences Inc (OTCPK:RASP) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2525, New York, NY, USA, 10170

Website

https://www.rasna.com

Rasna Therapeutics Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.

Actavia Life Sciences (Actavia Life Sciences) Headlines

No Headlines